Company page
Annovis Bio, Inc.
Annovis Bio, Inc. (ticker: ANVS) is a public company based in America, with a market capitalization of approximately $70.6 million. The company focuses on developing therapies for neurodegenerative diseases. Annovis Bio aims to address significant unmet medical needs through its innovative research and development efforts.
- Ticker
- ANVS:NYSE
- Asset type
- Stock
- Market cap
- $77.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE
- Currency
- USD